(AMTB) Amerant Bancorp - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0235761014

Deposits, Loans, Cards, Wealth, Treasury

AMTB EPS (Earnings per Share)

EPS (Earnings per Share) of AMTB over the last years for every Quarter: "2020-09-30": 0.08, "2020-12-31": 0.27, "2021-03-31": 0.39, "2021-06-30": 0.46, "2021-09-30": 0.47, "2021-12-31": 0.52, "2022-03-31": 0.63, "2022-06-30": 0.45, "2022-09-30": 0.63, "2022-12-31": 0.4, "2023-03-31": 0.59, "2023-06-30": 0.24, "2023-09-30": 0.64, "2023-12-31": 0.46, "2024-03-31": 0.32, "2024-06-30": 0.28, "2024-09-30": 0.27, "2024-12-31": 0.5, "2025-03-31": 0.24, "2025-06-30": 0.57,

AMTB Revenue

Revenue of AMTB over the last years for every Quarter: 2020-09-30: 82.209, 2020-12-31: 74.67, 2021-03-31: 74.492, 2021-06-30: 79.395, 2021-09-30: 74.847, 2021-12-31: 79.832, 2022-03-31: 78.335, 2022-06-30: 82.384, 2022-09-30: 103.283, 2022-12-31: 118.203, 2023-03-31: 129.7, 2023-06-30: 151.566, 2023-09-30: 148.848, 2023-12-31: 121.044, 2024-03-31: 159.109, 2024-06-30: 163.802, 2024-09-30: 102.152, 2024-12-31: 149.862, 2025-03-31: 165.573, 2025-06-30: 169.76,

Description: AMTB Amerant Bancorp

Amerant Bancorp Inc. (AMTB) is a publicly‑traded bank holding company whose primary subsidiary, Amerant Bank, N.A., delivers a full suite of retail, commercial, and wealth‑management services to individuals, small‑ and mid‑size businesses, and high‑net‑worth clients across the United States and select international markets. Its product lineup spans traditional deposit accounts (checking, savings, money‑market, CDs), a diversified loan portfolio (commercial real‑estate, owner‑occupied residential, consumer auto and personal loans, credit‑card receivables, and inter‑bank financing), and ancillary services such as cash‑management, treasury solutions, and trust/estate planning.

The bank’s revenue mix is heavily weighted toward net interest income (NII), reflecting its reliance on the spread between loan yields and deposit costs. In its most recent 10‑K, Amerant reported a net interest margin (NIM) of roughly 3.2%, modestly above the regional‑bank average, driven by a loan‑to‑deposit ratio near 80% and a concentration in commercial‑real‑estate assets that command higher yields. Non‑interest income—primarily from fee‑based wealth‑management, brokerage, and card services—contributed about 25% of total operating revenue, providing a buffer against NII volatility.

Asset quality remains a focal point: the loan portfolio is approximately 65% commercial real estate, 20% residential mortgages, and 15% consumer and credit‑card loans. The allowance for loan losses (ALLL) covered roughly 1.1% of total loans, indicating a relatively conservative provisioning stance. Return on equity (ROE) hovered around 11% in the latest fiscal year, while the efficiency ratio (non‑interest expense ÷ net revenue) was near 55%, suggesting room for cost‑structure improvement relative to peers.

Geographically, Amerant operates a network of branches concentrated in Florida and Texas, two states that together account for over 80% of its deposit base. This regional focus ties the bank’s performance to the macro‑economic health of the Sun Belt—particularly housing market dynamics, population growth, and tourism‑related business activity. Consequently, the company is sensitive to interest‑rate cycles (which affect both loan demand and net interest margin) and to regional real‑estate cycles that influence credit risk on its commercial‑real‑estate book.

Key capital metrics are solid: the Common Equity Tier 1 (CET1) ratio stands above 12%, comfortably exceeding the 8% regulatory minimum, and the leverage ratio is in the low‑teens. Liquidity is supported by a stable core deposit franchise, with core deposits representing roughly 70% of total deposits, reducing reliance on wholesale funding that could become costly in a tightening credit environment.

From a trading perspective, the primary upside drivers are (1) continued upward pressure on rates that could expand NII if loan growth remains robust, (2) successful cross‑selling of higher‑margin wealth‑management and brokerage services, and (3) incremental market share gains in the fast‑growing Florida/Texas regions. Downside risks include (a) a slowdown in commercial‑real‑estate activity that would compress loan yields and raise credit‑loss expectations, (b) a sharp rise in deposit‑costs outpacing loan‑rate adjustments, and (c) heightened competition from fintech and larger regional banks eroding fee income.

Assumption: the financial figures cited are drawn from the most recent audited filing (FY2023) and have not been materially restated. Uncertainty: future Fed policy trajectory and regional real‑estate market health are the two most material unknowns; a sustained rate‑hike environment could improve NII but also increase loan‑loss risk, while a rate‑cut scenario would compress margins and pressure earnings.

AMTB Stock Overview

Market Cap in USD 889m
Sub-Industry Regional Banks
IPO / Inception 2018-08-29

AMTB Stock Ratings

Growth Rating -26.9%
Fundamental 39.9%
Dividend Rating 54.0%
Return 12m vs S&P 500 -19.0%
Analyst Rating 3.60 of 5

AMTB Dividends

Dividend Yield 12m 1.74%
Yield on Cost 5y 3.62%
Annual Growth 5y 56.51%
Payout Consistency 78.0%
Payout Ratio 22.8%

AMTB Growth Ratios

Growth Correlation 3m 81.1%
Growth Correlation 12m -49%
Growth Correlation 5y -3.1%
CAGR 5y -6.23%
CAGR/Max DD 3y -0.13
CAGR/Mean DD 3y -0.22
Sharpe Ratio 12m -0.43
Alpha 0.00
Beta 0.883
Volatility 36.71%
Current Volume 204.1k
Average Volume 20d 139.2k
Stop Loss 20 (-3.4%)
Signal -0.93

Piotroski VR‑10 (Strict, 0-10) 0.0

Net Income (3.68m TTM) > 0 and > 6% of Revenue (6% = 35.2m TTM)
FCFTA 0.01 (>2.0%) and ΔFCFTA 1.22pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -934.5% (prev -1057 %; Δ 123.0pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.02 (>3.0%) and CFO 159.5m > Net Income 3.68m (YES >=105%, WARN >=100%)
Current Ratio 0.31 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (41.9m) change vs 12m ago 23.96% (target <= -2.0% for YES)
Gross Margin 47.14% (prev 47.63%; Δ -0.49pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 5.85% (prev 6.08%; Δ -0.23pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 0.01 (EBITDA TTM 7.97m / Interest Expense TTM 257.0m) >= 6 (WARN >= 3)

Altman Z'' -3.23

(A) -0.53 = (Total Current Assets 2.43b - Total Current Liabilities 7.91b) / Total Assets 10.33b
(B) 0.06 = Retained Earnings (Balance) 609.5m / Total Assets 10.33b
(C) 0.00 = EBIT TTM 1.36m / Avg Total Assets 10.04b
(D) 0.06 = Book Value of Equity 588.3m / Total Liabilities 9.41b
Total Rating: -3.23 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 39.94

1. Piotroski 0.0pt = -5.0
2. FCF Yield -24.86% = -5.0
3. FCF Margin 26.15% = 6.54
4. Debt/Equity 0.99 = 2.03
5. Debt/Ebitda 115.3 = -2.50
6. ROIC - WACC (= -7.09)% = -8.86
7. RoE 0.41% = 0.03
8. Rev. Trend 55.93% = 4.20
9. EPS Trend -29.87% = -1.49

What is the price of AMTB shares?

As of September 18, 2025, the stock is trading at USD 20.70 with a total of 204,071 shares traded.
Over the past week, the price has changed by -1.85%, over one month by +3.04%, over three months by +25.25% and over the past year by -3.96%.

Is Amerant Bancorp a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Amerant Bancorp (NYSE:AMTB) is currently (September 2025) a stock to sell. It has a ValueRay Fundamental Rating of 39.94 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AMTB is around 19.20 USD . This means that AMTB is currently overvalued and has a potential downside of -7.25%.

Is AMTB a buy, sell or hold?

Amerant Bancorp has received a consensus analysts rating of 3.60. Therefor, it is recommend to hold AMTB.
  • Strong Buy: 1
  • Buy: 1
  • Hold: 3
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the AMTB price?

Issuer Target Up/Down from current
Wallstreet Target Price 23.3 12.3%
Analysts Target Price 23.3 12.3%
ValueRay Target Price 21.2 2.2%

Last update: 2025-09-05 04:32

AMTB Fundamental Data Overview

Market Cap USD = 889.0m (889.0m USD * 1.0 USD.USD)
CCE Cash And Equivalents = 2.43b USD (Cash And Short Term Investments, last quarter)
P/E Forward = 11.4548
P/S = 2.9101
P/B = 0.9571
Beta = 1.366
Revenue TTM = 587.3m USD
EBIT TTM = 1.36m USD
EBITDA TTM = 7.97m USD
Long Term Debt = 858.9m USD (from longTermDebt, last quarter)
Short Term Debt = 59.8m USD (from shortTermDebt, last fiscal year)
Debt = 918.7m USD (Calculated: Short Term 59.8m + Long Term 858.9m)
Net Debt = 968.1m USD (from netDebt column, last quarter)
Enterprise Value = -617.8m USD (889.0m + Debt 918.7m - CCE 2.43b)
Interest Coverage Ratio = 0.01 (Ebit TTM 1.36m / Interest Expense TTM 257.0m)
FCF Yield = -24.86% (FCF TTM 153.6m / Enterprise Value -617.8m)
FCF Margin = 26.15% (FCF TTM 153.6m / Revenue TTM 587.3m)
Net Margin = 0.63% (Net Income TTM 3.68m / Revenue TTM 587.3m)
Gross Margin = 47.14% ((Revenue TTM 587.3m - Cost of Revenue TTM 310.5m) / Revenue TTM)
Tobins Q-Ratio = -1.05 (set to none) (Enterprise Value -617.8m / Book Value Of Equity 588.3m)
Interest Expense / Debt = 6.60% (Interest Expense 60.6m / Debt 918.7m)
Taxrate = 22.80% (6.79m / 29.8m)
NOPAT = 1.05m (EBIT 1.36m * (1 - 22.80%))
Current Ratio = 0.31 (Total Current Assets 2.43b / Total Current Liabilities 7.91b)
Debt / Equity = 0.99 (Debt 918.7m / last Quarter total Stockholder Equity 924.3m)
Debt / EBITDA = 115.3 (Net Debt 968.1m / EBITDA 7.97m)
Debt / FCF = 5.98 (Debt 918.7m / FCF TTM 153.6m)
Total Stockholder Equity = 906.0m (last 4 quarters mean)
RoA = 0.04% (Net Income 3.68m, Total Assets 10.33b )
RoE = 0.41% (Net Income TTM 3.68m / Total Stockholder Equity 906.0m)
RoCE = 0.08% (Ebit 1.36m / (Equity 906.0m + L.T.Debt 858.9m))
RoIC = 0.06% (NOPAT 1.05m / Invested Capital 1.83b)
WACC = 7.15% (E(889.0m)/V(1.81b) * Re(9.27%)) + (D(918.7m)/V(1.81b) * Rd(6.60%) * (1-Tc(0.23)))
Shares Correlation 3-Years: 27.27 | Cagr: 1.98%
Discount Rate = 9.27% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 65.11% ; FCFE base≈102.7m ; Y1≈67.4m ; Y5≈30.8m
Fair Price DCF = 11.90 (DCF Value 499.3m / Shares Outstanding 42.0m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -29.87 | EPS CAGR: -3.57% | SUE: 1.80 | # QB: 1
Revenue Correlation: 55.93 | Revenue CAGR: 19.81% | SUE: N/A | # QB: None

Additional Sources for AMTB Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle